Related Experiment Videos
Prevalence of Meibomian gland dysfunction
M M Hom1, J R Martinson, L L Knapp
1Southern California College of Optometry, Fullerton.
Summary
Meibomian gland dysfunction (MGD) affects 38.9% of patients. Advanced age is the primary risk factor associated with this common vision condition, highlighting the need for targeted interventions.
Area of Science:
- Ophthalmology
- Optometry
- Clinical Research
Background:
- Meibomian gland dysfunction (MGD) is a prevalent condition affecting ocular surface health.
- Understanding MGD prevalence and associated risk factors is crucial for effective patient management.
Purpose of the Study:
- To determine the prevalence of Meibomian gland dysfunction (MGD) in a general patient population.
- To identify patient profile factors correlated with the presence of MGD.
Main Methods:
- A cross-sectional study involving 398 patients undergoing routine vision examinations.
- Meibomian gland expression and detailed patient history were collected.
- Statistical analysis was performed to correlate MGD with gender, age, allergy, and contact lens wear.
Main Results:
- The prevalence of Meibomian gland dysfunction (MGD) was found to be 38.9% (155 out of 398 patients).
- Age was the only statistically significant correlating factor, showing a positive correlation with MGD (p < 0.0001).
- No significant correlation was found between MGD and gender, allergy occurrence, or contact lens wear.
Conclusions:
- Meibomian gland dysfunction (MGD) is highly prevalent in patients seeking routine eye care.
- Increasing age is a significant risk factor for developing Meibomian gland dysfunction (MGD).
- Further research may explore the mechanisms linking age to MGD and develop age-specific preventative strategies.